top of page
A Phase I study of a new drug candidate for high grade brain tumors. (Gallium Maltolate)
01:01:51
Meet Michael Barish, Ph.D. | City of Hope
01:21
Dr. Theodore Schwartz, Weill Cornell Medicine, and Gleolan (with voiceover)
Introducing GammaTile Therapy
04:40
Experimental Glioblastoma Vaccine Shows Promise in Slowing Brain Tumor Growth
00:52
Artificial Intelligence May Predict Drugs That Treat Glioblastoma
00:37
AutoLITT - A Minimally Invasive Brain Tumor Treatment
03:30
Cleveland Clinic's Brain Tumor Center
Gene Barnett, MD, MBA | Cleveland Clinic Brain Tumor & Neuro-Oncology
01:55
bottom of page